MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Balance Sheets Overview

Current Ratio
65.51%
Quick Ratio
50.16%
Cash Ratio
18.37%
Debt to Asset Ratio
101.98%
Unit: Thousand (K) dollars
Assets Breakdown
    • Right-of-use asset
    • Accounts receivable, net of allo...
    • Cash and cash equivalents
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Current maturities of long-term ...
    • Others
Balance Sheets
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Cash and cash equivalents
4,413
4,813
6,249
7,536
Accounts receivable, net of allowances of 421 and 164 as of june 30, 2026 and december 31, 2025
6,786
7,152
7,550
7,427
Inventories - net
3,686
4,481
5,281
4,002
Prepaid expenses and other current assets
852
1,311
1,554
2,348
Total current assets
15,737
17,757
20,634
21,313
Property and equipment - net
7,172
7,510
7,823
8,193
Restricted cash
1,522
1,522
1,522
1,522
Right-of-use asset
10,612
10,769
10,924
11,075
Patents - net
2,864
2,952
3,226
-
Other assets
53
52
53
3,647
Total assets
37,960
40,562
44,182
45,750
Accounts payable
2,002
3,132
2,869
3,035
Accrued expenses and other current liabilities
7,283
5,960
6,299
6,559
Lease liability - current portion
589
565
541
518
Current maturities of long-term debt, net of debt discount
14,149
6,646
-
-
Total current liabilities
24,023
16,303
9,709
10,112
Lease liability, net of current portion
11,596
11,752
11,903
12,051
Long-term debt, net of current portion and debt discount
3,092
10,313
16,667
14,567
Total liabilities
38,711
38,368
38,279
36,730
Common stock, par value 0.001, 100,000,000 shares authorized 62,842,748 and 62,804,305 shares issued and outstanding as of june 30, 2026 and december 31, 2025 respectively
63
63
63
63
Additional paid-in capital
321,936
321,568
321,024
319,511
Accumulated other comprehensive loss
-996
-2,101
-2,977
-3,844
Accumulated deficit
-321,754
-317,336
-312,207
-306,710
Total stockholders' equity (deficit)
-751
2,194
5,903
9,020
Total liabilities and stockholders' equity (deficit)
37,960
40,562
44,182
45,750
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Accounts receivable, netof allowances of...$6,786K (-12.36%↓ Y/Y)Cash and cashequivalents$4,413K (-56.75%↓ Y/Y)Inventories - net$3,686K (-0.65%↓ Y/Y)Prepaid expenses andother current assets$852K (-35.94%↓ Y/Y)Total current assets$15,737K (-31.54%↓ Y/Y)Right-of-use asset$10,612K (-5.44%↓ Y/Y)Property and equipment -net$7,172K (-15.28%↓ Y/Y)Patents - net$2,864K (-23.40%↓ Y/Y)Restricted cash$1,522K (0.00%↑ Y/Y)Other assets$53K (-98.60%↓ Y/Y)Total assets$37,960K (-20.90%↓ Y/Y)Accumulated deficit-$321,754K (-6.00%↓ Y/Y)Accumulated othercomprehensive loss-$996K (74.85%↑ Y/Y)Total liabilities andstockholders' equity...$37,960K (-20.90%↓ Y/Y)Total stockholders'equity (deficit)-$751K (-106.48%↓ Y/Y)Additional paid-in capital$321,936K (0.91%↑ Y/Y)Common stock, par value0.001, 100,000,000...$63K (0.00%↑ Y/Y)Total liabilities$38,711K (6.34%↑ Y/Y)Total currentliabilities$24,023K (144.09%↑ Y/Y)Lease liability, netof current portion$11,596K (-4.83%↓ Y/Y)Long-term debt, net ofcurrent portion and debt...$3,092K (-78.49%↓ Y/Y)Current maturities oflong-term debt, net of debt...$14,149K Accrued expenses andother current...$7,283K (22.34%↑ Y/Y)Accounts payable$2,002K (-41.01%↓ Y/Y)Lease liability -current portion$589K (18.99%↑ Y/Y)

Cytosorbents Corp (CTSO)

Cytosorbents Corp (CTSO)